Genetically modified tumour cells expressing IL-15 and IL-15Ralpha as an in situ cancer vaccination platform

Abstract

Interleukin-15 (IL-15) is a pleiotropic cytokinewith the ability to increase the effectiveness ofvaccines through enhancement of both innateand adaptive immune responses